WILLIAM BRYANT: Open Payments
NPI 1821609082 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,086 in 69 payments from 14 companies in 2025. Trend: 2023 $983 · 2024 $1,231 · 2025 $1,086
Food & beverage: $1,086
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $327 |
| Novartis Pharmaceuticals Corporation | 18 | $185 |
| Amgen Inc. | 12 | $151 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 8 | $123 |
| Novo Nordisk Inc | 3 | $54 |
| Merck Sharp & Dohme LLC | 3 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $44 |
| Alnylam Pharmaceuticals Inc. | 2 | $34 |
| Boston Scientific Corporation | 1 | $26 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
Products named: FARXIGA, LEQVIO, REPATHA, LifeVest, LOKELMA, VERQUVO, JARDIANCE, ELIQUIS.
Industry payments across MO — which companies pay providers there.
